Biocompatible Coatings to

Enhance Your Medical Device

Advancements in medical devices have demanded innovative coatings to enhance the biological acceptance and reduce the challenges faced when artificial materials are in contact with the body.

BioInteractions’ Biocompatible Coatings 

BioInteractions have developed three unique polymer coatings to help with these challenges:

Astute® 

Anti-thrombogenic Coating

Triple-Endothelial Action

Astute functionalises an active component within its polymer backbone and is combined with passive components to actively prevents a thrombus from forming.


Astute® Triple Endothelial Action:

  • Actively negates platelet activation
  • Prevents protein and cellular deposition
  • Non-leaching coating to give long term efficacy

AvertPlus

Dual Active Contact Kill Mechanism

Antimicrobial Coating

AvertPlus™ reduces device related infections and targets biofilm formation. The active contact kill mechanism is paired with a passive process to reduce the presence of bacteria on the surface


AvertPlus™ Dual Active Contact Kill Mechanism:

  • Active disruption of a broad-spectrum bacteria that results in lysis
  • Prevents deposition and adhesion of proteins
  • Non-leaching coating gives long term efficacy throughout lifetime of the coating

Assist™ 

Enhanced Lubricious Activity

Hydrophilic Coating

Assist™ minimises the obstacles faced at the device-body interface. The polymer coating provides a highly hydrophilic surface which reduces friction as well as preventing protein binding and platelet deposition to improve patient well-being.


Assist™ Enhanced Lubricity:

  • Hydrophilic properties as well as prevents deposition onto the surface
  • Non-leaching, non-cytotoxic and stable coating
  • Available as UV Cured or Heat Cured

Commitment to Care Services

Our Commitment to Care Service (C2C) builds on our expertise in facing a broad range of challenges. We have combined our innovative coatings with optimised application processes and support services as a complete solution for our partners. We have discovered the impact of applying the coating on the result of the quality and efficacy of the coating. We are able to develop and optimise a coating process as well as provide the coating capabilities in our cleanroom facilities for our customers.


We have extended our C2C services to include testing methods to highlight the benefits of using our coating technology. This can be used to help support regulatory submissions. We have expertise in helping our partners through the submission process helping to reduce significant challenges during this process

Our in-depth understanding of the range of challenges faced by materials, provides us with an exclusive advantage to help our partners. Our coating technologies provide innovative advantages to the device and helps to Assist™ in improving patient well-being.

Back To Top 

Go to article: Home | The Surgical Robot RevolutionGo to article: Formacoat Company InsightGo to article: FormacoatGo to article: In This IssueGo to article: Telemed Company InsightGo to article: TelemedGo to article: ContentsGo to article: Accurate Biometrics Company InsightGo to article: Accurate BiometricsGo to article: The magic touch: bringing sensory feedback to brain-controlled prostheticsGo to article: Picosun Company Insight Go to article: PicosunGo to article: Medicoat Go to article: The high-tech hunt for new biomarkersGo to article: MPS Microsystems Company InsightGo to article: MPS MicrosystemsGo to article: OmnitronGo to article: Making robotic surgery safe: why training is key to avoiding tragedy Go to article: BioInteractions Company Insight Go to article: BioInteractions Go to article: XavitechGo to article: Virtual pain relief: could VR start a rehab revolution?Go to article: Industrial Indexing Systems Company Insight Go to article: Industrial Indexing SystemsGo to article: Low battery: finding alternative ways to power medical devicesGo to article: Key Plastics Company Insight Go to article: Key PlasticsGo to article: NSFGo to article: Hidden figures: lifting the lid on medical device failure reportingGo to article: Protomatic Medical Company InsightGo to article: Protomatic MedicalGo to article: Watlow Plasmatech Company Insight Go to article: WatlowGo to article: Making sustainable medical devices: five top tipsGo to article: ARPA Company InsightGo to article: ARPAGo to article: ICU techGo to article: Predicting cardiac risk: new approaches in AI and blood testingGo to article: Under the skin: the medical device industry and the dark webGo to article: Sandvik Company InsightGo to article: Sandvik Go to article: Q&A: LifeBank on the challenge of getting blood from A to B in Nigeria Go to article: Cap Biomaterials Company Insight Go to article: Cap BiomaterialsGo to article: Debate: Can Alexa be trusted with our health questions?Go to article: AtoZ-CRO Company InsightGo to article: AtoZ-CRO Go to article: Pleora TechnologiesGo to article: Maraca InternationalGo to article: Europlasma Company Insight Go to article: EuroplasmaGo to article: Combinostics Company Insight Go to article: EventsGo to article: Euroquartz Company InsightGo to article: EuroquartzGo to article: Next issueGo to article: mdi ConsultantsGo to article: Ginolis Company InsightGo to article: GinolisGo to article: Sab BroeckskesGo to article: Qmedics Company Insight Go to article: Qmedics